Cargando…
Construction of a prognostic model for radical esophagectomy based on immunohistochemical prognostic markers combined with clinicopathological factors
Esophageal squamous cell carcinoma (ESCC) has a poor prognosis and lacks effective biomarkers to evaluate prognosis and treatment. Glycoprotein nonmetastatic melanoma protein B (GPNMB) is a protein highly expressed in ESCC tissues screened by isobaric tags for relative and absolute quantitation prot...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981367/ https://www.ncbi.nlm.nih.gov/pubmed/36862875 http://dx.doi.org/10.1097/MD.0000000000032889 |
_version_ | 1784900085446868992 |
---|---|
author | Wang, Bo Su, Anna Li, Mengyan Wang, Xuecheng Gao, Yongmei Su, Liping Li, Wan Ma, Yuqing |
author_facet | Wang, Bo Su, Anna Li, Mengyan Wang, Xuecheng Gao, Yongmei Su, Liping Li, Wan Ma, Yuqing |
author_sort | Wang, Bo |
collection | PubMed |
description | Esophageal squamous cell carcinoma (ESCC) has a poor prognosis and lacks effective biomarkers to evaluate prognosis and treatment. Glycoprotein nonmetastatic melanoma protein B (GPNMB) is a protein highly expressed in ESCC tissues screened by isobaric tags for relative and absolute quantitation proteomics, which has significant prognostic value in a variety of malignant tumors, but its relationship with ESCC remains unclear. By immunohistochemical staining of 266 ESCC samples, we analyzed the relationship between GPNMB and ESCC. To explore how to improve the ability of ESCC prognostic assessment, we established a prognostic model of GPNMB and clinicopathological features. The results suggest that GPNMB expression is generally positive in ESCC tissues and is significantly associated with poorer differentiation, more advanced American Joint Council on Cancer (AJCC) stage, and higher tumor aggressiveness (P < .05). Multivariate Cox analysis indicated that GPNMB expression was an independent risk factor for ESCC patients. A total of 188 (70%) patients were randomly selected from the training cohort and the four variables were automatically screened by stepwise regression based on the AIC principle: GPNMB expression, nation, AJCC stage and nerve invasion. Through the weighted term, we calculate the risk score of each patient, and by drawing the receiver operating characteristic curve, we show that the model has good prognostic evaluation performance. The stability of the model was verified by test cohort. Conclusion: GPNMB is a prognostic marker consistent with the characteristics of tumor therapeutic targets. For the first time, we constructed a prognostic model combining immunohistochemical prognostic markers and clinicopathological features in ESCC, which showed higher prognostic efficacy than AJCC staging system in predicting the prognosis of ESCC patients in this region. |
format | Online Article Text |
id | pubmed-9981367 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-99813672023-03-04 Construction of a prognostic model for radical esophagectomy based on immunohistochemical prognostic markers combined with clinicopathological factors Wang, Bo Su, Anna Li, Mengyan Wang, Xuecheng Gao, Yongmei Su, Liping Li, Wan Ma, Yuqing Medicine (Baltimore) 4500 Esophageal squamous cell carcinoma (ESCC) has a poor prognosis and lacks effective biomarkers to evaluate prognosis and treatment. Glycoprotein nonmetastatic melanoma protein B (GPNMB) is a protein highly expressed in ESCC tissues screened by isobaric tags for relative and absolute quantitation proteomics, which has significant prognostic value in a variety of malignant tumors, but its relationship with ESCC remains unclear. By immunohistochemical staining of 266 ESCC samples, we analyzed the relationship between GPNMB and ESCC. To explore how to improve the ability of ESCC prognostic assessment, we established a prognostic model of GPNMB and clinicopathological features. The results suggest that GPNMB expression is generally positive in ESCC tissues and is significantly associated with poorer differentiation, more advanced American Joint Council on Cancer (AJCC) stage, and higher tumor aggressiveness (P < .05). Multivariate Cox analysis indicated that GPNMB expression was an independent risk factor for ESCC patients. A total of 188 (70%) patients were randomly selected from the training cohort and the four variables were automatically screened by stepwise regression based on the AIC principle: GPNMB expression, nation, AJCC stage and nerve invasion. Through the weighted term, we calculate the risk score of each patient, and by drawing the receiver operating characteristic curve, we show that the model has good prognostic evaluation performance. The stability of the model was verified by test cohort. Conclusion: GPNMB is a prognostic marker consistent with the characteristics of tumor therapeutic targets. For the first time, we constructed a prognostic model combining immunohistochemical prognostic markers and clinicopathological features in ESCC, which showed higher prognostic efficacy than AJCC staging system in predicting the prognosis of ESCC patients in this region. Lippincott Williams & Wilkins 2023-03-03 /pmc/articles/PMC9981367/ /pubmed/36862875 http://dx.doi.org/10.1097/MD.0000000000032889 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. |
spellingShingle | 4500 Wang, Bo Su, Anna Li, Mengyan Wang, Xuecheng Gao, Yongmei Su, Liping Li, Wan Ma, Yuqing Construction of a prognostic model for radical esophagectomy based on immunohistochemical prognostic markers combined with clinicopathological factors |
title | Construction of a prognostic model for radical esophagectomy based on immunohistochemical prognostic markers combined with clinicopathological factors |
title_full | Construction of a prognostic model for radical esophagectomy based on immunohistochemical prognostic markers combined with clinicopathological factors |
title_fullStr | Construction of a prognostic model for radical esophagectomy based on immunohistochemical prognostic markers combined with clinicopathological factors |
title_full_unstemmed | Construction of a prognostic model for radical esophagectomy based on immunohistochemical prognostic markers combined with clinicopathological factors |
title_short | Construction of a prognostic model for radical esophagectomy based on immunohistochemical prognostic markers combined with clinicopathological factors |
title_sort | construction of a prognostic model for radical esophagectomy based on immunohistochemical prognostic markers combined with clinicopathological factors |
topic | 4500 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981367/ https://www.ncbi.nlm.nih.gov/pubmed/36862875 http://dx.doi.org/10.1097/MD.0000000000032889 |
work_keys_str_mv | AT wangbo constructionofaprognosticmodelforradicalesophagectomybasedonimmunohistochemicalprognosticmarkerscombinedwithclinicopathologicalfactors AT suanna constructionofaprognosticmodelforradicalesophagectomybasedonimmunohistochemicalprognosticmarkerscombinedwithclinicopathologicalfactors AT limengyan constructionofaprognosticmodelforradicalesophagectomybasedonimmunohistochemicalprognosticmarkerscombinedwithclinicopathologicalfactors AT wangxuecheng constructionofaprognosticmodelforradicalesophagectomybasedonimmunohistochemicalprognosticmarkerscombinedwithclinicopathologicalfactors AT gaoyongmei constructionofaprognosticmodelforradicalesophagectomybasedonimmunohistochemicalprognosticmarkerscombinedwithclinicopathologicalfactors AT suliping constructionofaprognosticmodelforradicalesophagectomybasedonimmunohistochemicalprognosticmarkerscombinedwithclinicopathologicalfactors AT liwan constructionofaprognosticmodelforradicalesophagectomybasedonimmunohistochemicalprognosticmarkerscombinedwithclinicopathologicalfactors AT mayuqing constructionofaprognosticmodelforradicalesophagectomybasedonimmunohistochemicalprognosticmarkerscombinedwithclinicopathologicalfactors |